Phototoxic erythema following PUVA treatment: independence of complement.

The effect of PUVA treatment on normal human serum (NHS), on isolated PMN, or on C3-deficient guinea pigs and congenic (C3-competent) control animals was tested. At a concentration of 0.1 or 1 mM/l 8-MOP and UVA doses of 5-30 J/cm2, PUVA failed to induce any detectable C3-cleavage in NHS. Furthermore, when the complement (C) activation in NHS had been induced before or after PUVA treatment by various methods. PUVA did not modulate the extent of C3-cleavage. PUVA did not affect the viability of isolated PMN, nor did it induce a release of LDH or elastase. No differences between C3-deficient and C-competent guinea pig skin exposed to PUVA were observed in erythema or histologic responses. Immunohistologic examination of specimens from normal guinea pigs revealed C3b and C3d deposits on necrotic keratinocytes, findings restricted to the PUVA-treated areas. Necrosis of keratinocytes was present in skin specimens of C3-deficient animals from PUVA-treated sites to a similar extent. However, deposits of C3-related antigens were completely absent there. From these observations, we suggest that the induction of phototoxic erythema following PUVA treatment is independent of complement.

[1]  B. Diffey,et al.  PUVA-induced blisters, complement deposition, and damage to the dermoepidermal junction. , 1987, Archives of dermatology.

[2]  H. Tagami,et al.  Role of complement in chlorpromazine-induced phototoxicity. , 1986, The Journal of investigative dermatology.

[3]  W. Hörl,et al.  Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. , 1985, Kidney international.

[4]  C. Haslett,et al.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. , 1985, The American journal of pathology.

[5]  I. Gigli,et al.  Delayed phase of hematoporphyrin-induced phototoxicity: modulation by complement, leukocytes, and antihistamines. , 1985, The Journal of investigative dermatology.

[6]  Gange Rw,et al.  Cutaneous phototoxicity due to psoralens. , 1984 .

[7]  I. Gigli,et al.  Activation of the complement system in patients with porphyrias after irradiation in vivo. , 1984, The Journal of clinical investigation.

[8]  A. Forsgren,et al.  Effects of in vitro PUVA on human leukocyte function , 1984, The British journal of dermatology.

[9]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  I. Gigli,et al.  Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs. Inhibition by decomplementation in vivo. , 1983, The Journal of clinical investigation.

[11]  M. Shin,et al.  Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Danno,et al.  The alterations of keratinocyte surface and basement membrane markers by treatment with 8-methoxypsoralen plus long-wave ultraviolet light. , 1983, The Journal of investigative dermatology.

[13]  D. Bitter‐Suermann,et al.  Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies. , 1982, Journal of immunology.

[14]  H. Roenigk,et al.  Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients. , 1982, Journal of the American Academy of Dermatology.

[15]  R. Tarone,et al.  Inhibition of mixed leukocyte culture reaction by 8-methoxypsoralen and long-wavelength ultraviolet radiation. , 1981, The Journal of investigative dermatology.

[16]  H. Pehamberger,et al.  Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis. , 1980, The Journal of investigative dermatology.

[17]  H. Hönigsmann,et al.  Long‐term photochemotherapy: histopathological and immunofluorescence observations in 243 patients , 1980, The British journal of dermatology.

[18]  P. Baker,et al.  Activation of human complement by heat-killed, human kidney cells grown in cell culture. , 1980, Journal of immunology.

[19]  C. Wermuth,et al.  The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. , 1974, Biochemical medicine.

[20]  C. Laurell,et al.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. , 1965, Analytical biochemistry.

[21]  J. Gordon,et al.  An inherited deficiency of the third component of complement, C3, in guinea pigs , 1986, European journal of immunology.

[22]  O. Clemmensen,et al.  Activation of complement in the skin after PUVA therapy. , 1984, Acta dermato-venereologica.

[23]  J. Hau,et al.  Charge and size heterogeneity of C3d following in vivo and in vitro activation of the complement system. , 1984, Complement.